Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Sterile compounding: clinical, legal, and regulatory implications for patient safety.

Qureshi N, Wesolowicz L, Stievater T, et al. Sterile compounding: clinical, legal, and regulatory implications for patient safety. J Manag Care Spec Pharm. 2014;20(12):1183-1191.

Save
Print
February 4, 2015
Qureshi N, Wesolowicz L, Stievater T, et al. J Manag Care Spec Pharm. 2014;20(12):1183-1191.
View more articles from the same authors.

Failure to follow safety practices at a compounding pharmacy led to a widespread outbreak of fungal meningitis in 2013, resulting in more than 60 deaths. This review discusses the epidemic and the regulations that have been put into place to improve oversight of compounding pharmacies.

Save
Print
Cite
Citation

Qureshi N, Wesolowicz L, Stievater T, et al. Sterile compounding: clinical, legal, and regulatory implications for patient safety. J Manag Care Spec Pharm. 2014;20(12):1183-1191.

Related Resources From the Same Author(s)
Related Resources